- Reply to correspondence on “Comparison of four histological scoring systems for autoimmune hepatitis to improve diagnostic sensitivity”
-
Komori A
- KMID: 2560120
- Clin Mol Hepatol.
- 2024 Oct;30(4):1035-1036.
- doi: 10.3350/cmh.2024.0242
-
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of the histological scoring systems of autoimmune hepatitis: A significant step towards the optimization of clinical diagnosis
-
Komori A
- KMID: 2554418
- Clin Mol Hepatol.
- 2024 Apr;30(2):157-159.
- doi: 10.3350/cmh.2024.0131
-
- CITED
-
- Close
- SHARE
-
- Close
- Recent updates on the management of autoimmune hepatitis
-
Komori A
- KMID: 2511450
- Clin Mol Hepatol.
- 2021 Jan;27(1):58-69.
- doi: 10.3350/cmh.2020.0189
Autoimmune hepatitis (AIH) is an immunoinflammatory chronic liver disease with dynamic and rather heterogeneous disease manifestations. A trend of increasing prevalence of AIH has been observed worldwide, along with a... -
- CITED
-
- Close
- SHARE
-
- Close
- Hard-to-treat autoimmune hepatitis and primary biliary cholangitis: The dawn of a new era of pharmacological treatment
-
Komori A, Kugiyama Y
- KMID: 2563409
- Clin Mol Hepatol.
- 2025 Jan;31(1):90-104.
- doi: 10.3350/cmh.2024.0821
Patients with hard-to-treat autoimmune hepatitis (AIH) or primary biliary cholangitis (PBC) are defined a posteriori as those who do not show a sufficient response or are intolerant to pharmacological treatments,... -
- CITED
-
- Close
- SHARE
-
- Close
